Within-subject biological variation in disease: collated data and clinical consequences.
about
Fibroblast growth factor 23Mass spectrometry for translational proteomics: progress and clinical implicationsSelection of the appropriate method for the assessment of insulin resistanceBiological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome.Rationale for using data on biological variation.First data on the biological variation and quality specifications for plasma ammonia concentrations in healthy subjects.Generation of data on within-subject biological variation in laboratory medicine: An update.Immature platelet fraction measured on the Sysmex XN hemocytometer predicts thrombopoietic recovery after autologous stem cell transplantationAdverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study.Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis.Within-subject variability in repeated measures of salivary analytes in healthy adults.Routine internal- and external-quality control data in clinical laboratories for estimating measurement and diagnostic uncertainty using GUM principles.Pharmacokinetics and safety issues of an accidental overdose of 2,000,000 IU of vitamin D3 in two nursing home patients: a case report.Biochemistry on the human scaleEarly increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritisReference intervals, intraindividual and interindividual variability, and reference change values for hematologic variables in laboratory beaglesA new generation of biomarkers tests of myocardial necrosis: the real quality a physician can get from the laboratoryBone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patientsRepeating tests: different roles in research studies and clinical medicineAnalytical quality--what should we be aiming for?The Uncertainty of the eGFR.Hematologic and Biochemical Biologic Variation in Laboratory Cats.Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges.Subject-based reference values: biological variation, individuality, and reference change values.A checklist for critical appraisal of studies of biological variation.Acute Kidney Injury: Diagnostic Approaches and ControversiesBiological variation of cardiac troponin T in patients with end-stage renal disease and in healthy individuals.Biological variation of 20 analytes measured in serum from clinically healthy domestic cats.Interpretation of Biochemical Tests Using the Reference Change Value in Monitoring Adverse Effects of Oral Isotretinoin in 102 Ethnic Turkish Patients.The use of serial outpatient complete blood count (CBC) results to derive biologic variation: a new tool to gauge the acceptability of hematology testing.Biological variation of thromboelastrography variables in 10 clinically healthy horses.The Importance of Understanding Variation.Aging and death-associated changes in serum albumin variability over the course of chronic hemodialysis treatment.Within-individual hematocrit variations and self-monitoring of blood glucose.The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing.Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease.Analytical goals for thyroid function tests when monitoring patients with untreated subclinical hypothyroidism.Reference change values for insulin and insulin-like growth factor binding protein-1 (IGFBP-1) in individuals with varying degrees of glucose tolerance.Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality.Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies.
P2860
Q26829294-6606DEC0-A52C-4B7C-A7B7-4B13C8835C00Q26995497-A4832394-5337-480E-9ADD-F9C064AEC263Q27001024-BAC9933F-BCBE-4F35-A306-97D673849611Q30838126-AD92870D-D96F-4A38-8C01-2524373C9C6FQ30941315-21888948-1828-4FC2-A31D-5B3B34BC1E2BQ31004919-4759CC5A-8153-416B-9B70-1E1097E10A8EQ31043624-6DC318A1-1AA8-47BA-89BC-4BEDAC3F646DQ33414161-12C168FD-DE7E-43AD-A251-56FAA620D19CQ33601281-1AFAD6F0-54FD-4FA0-A689-48BDFE8C1009Q33944768-93D3F078-75BF-4515-83F1-1A5436F205D8Q34040232-F860467B-096B-4543-A3CA-858410737D1AQ34122991-774645A0-0B18-406C-B9F9-52A19AB60C68Q34289016-E15ABAC5-DEAC-4D0E-8EFB-2DB19F147C41Q34386678-F0D1F26A-40EB-472F-9518-EDAE249E0A34Q34894822-092B83A4-95C8-4A3D-A8AB-A37DE06622B8Q35031073-ECFF25D3-7537-4988-9EBB-C765DF72B4A3Q35052889-BD69F49A-024A-470F-AFAB-477CA4FD2C44Q36035872-54223572-22D3-4AA0-AA19-F7D26955CB22Q36837027-F5FA8FB1-677C-4EDA-872E-0AC627C6213AQ36915773-AD3FA129-D6FD-4116-B175-239EC501A89BQ36946194-F0BF4D23-99D4-4D94-BFF2-6CD96E38158AQ37269660-43ADBEA8-60E6-4595-9D34-A1EFB60BEEC2Q37363395-0DA0BD11-E853-4E86-A50D-4A5A4A2E1A11Q37990546-FB8821CD-C3FD-46DC-8CFE-60DF3E9BF3DFQ39004134-AF335EDA-0C4E-49F8-AA55-1DE387AA7563Q39123320-EA05E140-DC88-445B-A87A-02E5639E59BBQ39162704-1BC152E0-33BF-4699-845F-8BD3063FBEF9Q39379472-BC87B062-66C2-4F69-826B-4B77DB2AE25BQ39653226-48B7728A-6C87-46F8-B812-C74C068A54FEQ40196066-85091FD9-A7C7-4C73-9336-CCACD6919176Q40416922-841B1E4A-4DDC-4B6B-BED7-C4E7C893C734Q41944161-45A11853-0837-42E1-9042-F258A20E9D91Q41997271-D11AC69C-96B0-431E-BB96-E45D341F5FF1Q42142285-2D745C5A-8855-4F32-9BD0-197C06CAB4E2Q42935085-F805C8E7-6330-4D93-A8FD-43B35EA2ABB6Q43060201-26EE12E0-761D-4E4A-897E-4823A7D37689Q43080298-4EB9B794-A9AA-47B8-8B30-7FFD4575150FQ44229620-E7B704FE-A919-42E0-AACE-288F018CFC29Q44740638-10A1B05C-7BF0-456A-BAE3-D7DE096B79CDQ44840995-41C79B95-FB70-41B8-A95A-11B55CEC245B
P2860
Within-subject biological variation in disease: collated data and clinical consequences.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Within-subject biological variation in disease: collated data and clinical consequences.
@ast
Within-subject biological variation in disease: collated data and clinical consequences.
@en
type
label
Within-subject biological variation in disease: collated data and clinical consequences.
@ast
Within-subject biological variation in disease: collated data and clinical consequences.
@en
prefLabel
Within-subject biological variation in disease: collated data and clinical consequences.
@ast
Within-subject biological variation in disease: collated data and clinical consequences.
@en
P2093
P1476
Within-subject biological variation in disease: collated data and clinical consequences
@en
P2093
Amparo Hernández
Carlos-Victor Jiménez
Carmen Perich
Carmen Ricós
Fernando Cava
José-Vicente García-Lario
Margarita Simón
Maria-Vicenta Doménech
Natalia Iglesias
Raquel Tena
P304
P356
10.1258/000456307780945633
P577
2007-07-01T00:00:00Z